hemophilia A gene therapy (Immune)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehemophilia A gene therapy (Immune)
Drug Alias Namehemophilia A gene therapy (Immune/Bayer)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionCoagulation factor VIII stimulants
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmune Response Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer CorpImmune Response Biopharma Inc
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A